Skip to main content
Log in

Green coffee as a novel agent for Alzheimer’s disease prevention by attenuating diabetes

  • Review Article
  • Published:
Translational Neuroscience

Abstract

Diabetes type 2, caused mainly by insulin resistance, is growing in incidence worldwide. In addition to being a major public health concern, type 2 diabetes is also a risk factor for dementia, including Alzheimer’s disease type dementia. Coffee consumption is reported to have protective effects in both diabetes and Alzheimer’s disease. We review here the reported beneficial effects of coffee in both disease conditions and the previously identified active ingredients of coffee. Furthermore, we revisit our recent findings of improved glucose utilization in the periphery and in the brain in a mouse model of high-fat diet induced type 2 diabetes after treatment with a decaffeinated green coffee preparation. Overall, consumption of coffee appears to improve diabetes and reduce the risk of dementia, although future studies are required to further identify the active components and the type of coffee that is most effective in addressing these conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. International Diabetes Federation, IDF Diabetes Atlas, cited 2013 August 27, 5th Edition, 2012, available from: http://www.idf.org/diabetesatlas/5e/Update2012

  2. World Health Organization, Diabetes Fact Sheet, 1999, cited 2013 August 27, available from: http://www.who.int/mediacentre/factsheets/fs312/en/

  3. Alberti K. G., Zimmet P. Z., Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, Diabet. Med., 1998, 15, 539–553

    Article  CAS  PubMed  Google Scholar 

  4. Vagelatos N. T., Eslick G. D., Type 2 diabetes as a risk factor for Alzheimer’s disease: the confounders, interactions, and neuropathology associated with this relationship, Epidemiol. Rev., 2013, 35, 152–160

    Article  Google Scholar 

  5. Alzheimer’s Association, 2013 Alzheimer’s disease facts and figures, cited 2013 August 27, available from: http://www.alz.org/downloads/facts_figures_2013.pdf

  6. Butt M. S., Sultan M. T., Coffee and its consumption: benefits and risks, Crit. Rev. Food Sci. Nutr., 2011, 51, 363–373

    Article  CAS  PubMed  Google Scholar 

  7. van Dam R. M., Hu F. B., Coffee consumption and risk of type 2 diabetes: a systematic review, JAMA, 2005, 294, 97–104

    Article  PubMed  Google Scholar 

  8. Huxley R., Lee C. M., Barzi F., Timmermeister L., Czernichow S., Perkovic V., et al., Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis, Arch. Intern. Med., 2009, 169, 2053–2063

    Article  PubMed  Google Scholar 

  9. Muley A., Muley P., Shah M., Coffee to reduce risk of type 2 diabetes? A systematic review, Curr. Diabetes Rev., 2012, 8, 162–168

    Article  CAS  PubMed  Google Scholar 

  10. Reunanen A., Heliovaara M., Aho K., Coffee consumption and risk of type 2 diabetes mellitus, Lancet, 2003, 361, 702–703, author reply 703

    Article  PubMed  Google Scholar 

  11. Saremi A., Tulloch-Reid M., Knowler W. C., Coffee consumption and the incidence of type 2 diabetes, Diabetes Care, 2003, 26, 2211–2212

    Article  PubMed  Google Scholar 

  12. Floegel A., Pischon T., Bergmann M. M., Teucher B., Kaaks R., Boeing H., Coffee consumption and risk of chronic disease in the European Prospective Investigation into Cancer and Nutrition (EPIC) — Germany study, Am. J. Clin. Nutr., 2012, 95, 901–908

    Article  CAS  PubMed  Google Scholar 

  13. Pereira M. A., Parker E. D., Folsom A. R., Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women, Arch. Intern. Med., 2006, 166, 1311–1316

    Article  PubMed  Google Scholar 

  14. van Dam R. M., Willett W. C., Manson J. E., Hu F. B., Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women, Diabetes Care, 2006, 29, 398–403

    Article  PubMed  Google Scholar 

  15. Robinson L. E., Savani S., Battram D. S., McLaren D. H., Sathasivam P., Graham T. E., Caffeine ingestion before an oral glucose tolerance test impairs blood glucose management in men with type 2 diabetes, J. Nutr., 2004, 134, 2528–2533

    CAS  PubMed  Google Scholar 

  16. Kogure A., Sakane N., Takakura Y., Umekawa T., Yoshioka K., Nishino H., et al., Effects of caffeine on the uncoupling protein family in obese yellow KK mice, Clin. Exp. Pharmacol. Physiol., 2002, 29, 391–394

    Article  CAS  PubMed  Google Scholar 

  17. Yoshioka K., Yoshida T., Kamanaru K., Hiraoka N., Kondo M., (1990). Caffeine activates brown adipose tissue thermogenesis and metabolic rate in mice, J. Nutr. Sci. Vitaminol. (Tokyo), 1990, 36, 173–178

    Article  CAS  Google Scholar 

  18. Welsch C. A., Lachance P. A., Wasserman B. P., Dietary phenolic compounds: inhibition of Na+-dependent D-glucose uptake in rat intestinal brush border membrane vesicles, J. Nutr. 1989, 119, 1698–1704

    CAS  PubMed  Google Scholar 

  19. Hemmerle H., Burger H. J., Below P., Schubert G., Rippel R., Schindler P. W., et al., Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase, J. Med. Chem., 1997, 40, 137–145

    Article  CAS  PubMed  Google Scholar 

  20. Prabhakar P. K., Doble M., Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes, Phytomedicine, 2009, 16, 1119–1126

    Article  CAS  PubMed  Google Scholar 

  21. Lee K. J., Jeong H. G., Protective effects of kahweol and cafestol against hydrogen peroxide-induced oxidative stress and DNA damage, Toxicol. Lett., 2007, 173, 80–87

    Article  CAS  PubMed  Google Scholar 

  22. Bakuradze T., Lang R., Hofmann T., Stiebitz H., Bytof G., Lantz I., et al., Antioxidant effectiveness of coffee extracts and selected constituents in cell-free systems and human colon cell lines, Mol. Nutr. Food Res., 2010, 54, 1734–1743

    Article  CAS  PubMed  Google Scholar 

  23. Hu N., Yu J. T., Tan L., Wang Y. L., Sun L., Nutrition and the risk of Alzheimer’s disease, Biomed. Res. Int., 2013, 524820

  24. Barranco Quintana J. L., Allam M. F., Del Castillo A. S., Navajas R. F. C., Alzheimer’s disease and coffee: a quantitative review, Neurol. Res., 2007, 29, 91–95

    Article  PubMed  Google Scholar 

  25. Lindsay J., Laurin D., Verreault R., Hebert R., Helliwell B., Hill G. B., et al., Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian Study of Health and Aging, Am. J. Epidemiol., 2002, 156, 445–453

    Article  PubMed  Google Scholar 

  26. Eskelinen M. H., Ngandu T., Tuomilehto J., Soininen H., Kivipelto M., Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study, J. Alzheimers Dis., 2009, 16, 85–91

    CAS  PubMed  Google Scholar 

  27. Cao C., Loewenstein D. A., Lin X., Zhang C., Wang L., Duara R., et al., High blood caffeine levels in MCI linked to lack of progression to dementia, J. Alzheimers Dis., 2012, 30, 559–572

    CAS  PubMed  Google Scholar 

  28. Cao C., Wang L., Lin X., Mamcarz M., Zhang C., Bai G., et al., Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer’s mice, J. Alzheimers Dis., 2011, 25, 323–335

    CAS  PubMed  Google Scholar 

  29. Gelber R. P., Petrovitch H., Masaki K. H., Ross G. W., White L. R., Coffee intake in midlife and risk of dementia and its neuropathologic correlates, J. Alzheimers Dis., 2011, 23, 607–615

    CAS  PubMed Central  PubMed  Google Scholar 

  30. Chu Y. F., Chang W. H., Black R. M., Liu J. R., Sompol P., Chen Y., et al., Crude caffeine reduces memory impairment and amyloid beta(1–42) levels in an Alzheimer’s mouse model, Food Chem., 2012, 135, 2095–2102

    Article  CAS  PubMed  Google Scholar 

  31. Cao C., Cirrito J. R., Lin X., Wang L., Verges D. K., Dickson A., et al., Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer’s disease transgenic mice, J. Alzheimers Dis., 2009, 17, 681–697

    CAS  PubMed Central  PubMed  Google Scholar 

  32. Arendash G. W., Mori T., Cao C., Mamcarz M., Runfeldt M., Dickson A., et al., Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer’s disease mice, J. Alzheimers Dis., 2009, 17, 661–680

    CAS  PubMed  Google Scholar 

  33. Arendash G. W., Schleif W., Rezai-Zadeh K., Jackson E. K., Zacharia L. C., Cracchiolo J. R., et al., Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain beta-amyloid production, Neuroscience, 2006, 142, 941–952

    Article  CAS  PubMed  Google Scholar 

  34. Fredholm B. B., Battig K., Holmen J., Nehlig A., Zvartau E. E., Actions of caffeine in the brain with special reference to factors that contribute to its widespread use, Pharmacol. Rev., 1999, 51, 83–133

    CAS  PubMed  Google Scholar 

  35. Canas P. M., Porciuncula L. O., Cunha G. M., Silva C. G., Machado N. J., Oliveira J. M., et al., Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway, J. Neurosci., 2009, 29, 14741–14751

    Article  CAS  PubMed  Google Scholar 

  36. Angulo E., Casado V., Mallol J., Canela E. I., Vinals F., Ferrer I., et al., A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation, Brain Pathol., 2003, 13, 440–451

    Article  CAS  PubMed  Google Scholar 

  37. Dostal V., Roberts C. M., Link C. D., Genetic mechanisms of coffee extract protection in a Caenorhabditis elegans model of betaamyloid peptide toxicity, Genetics, 2010, 186, 857–866

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Evans M. J., Scarpulla R. C., Interaction of nuclear factors with multiple sites in the somatic cytochrome c promoter. Characterization of upstream NRF-1, ATF, and intron Sp1 recognition sequences, J. Biol. Chem., 1989, 264, 14361–14368

    CAS  PubMed  Google Scholar 

  39. Trinh K., Andrews L., Krause J., Hanak T., Lee D., Gelb M., et al., Decaffeinated coffee and nicotine-free tobacco provide neuroprotection in Drosophila models of Parkinson’s disease through an NRF2-dependent mechanism, J. Neurosci., 2010, 30, 5525–5532

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  40. Tohda C., Kuboyama T., Komatsu K., Search for natural products related to regeneration of the neuronal network, Neurosignals, 2005, 14, 34–45

    Article  CAS  PubMed  Google Scholar 

  41. Kwon S. H., Lee H. K., Kim J. A., Hong S. I., Kim H. C., Jo T. H., et al., Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice, Eur. J. Pharmacol., 2010, 649, 210–217

    Article  CAS  PubMed  Google Scholar 

  42. Cho E. S., Jang Y. J., Hwang M. K., Kang N. J., Lee K. W., Lee H. J., Attenuation of oxidative neuronal cell death by coffee phenolic phytochemicals, Mutat. Res., 2009, 661, 18–24

    Article  CAS  PubMed  Google Scholar 

  43. Ho L., Varghese M., Wang J., Zhao W., Chen F., Knable L. A., et al., Dietary supplementation with decaffeinated green coffee improves diet-induced insulin resistance and brain energy metabolism in mice, Nutr. Neurosci., 2012, 15, 37–45

    Article  CAS  PubMed  Google Scholar 

  44. Ho L., Qin W., Pompl P. N., Xiang Z., Wang J., Zhao Z., et al., Dietinduced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease, FASEB J., 2004, 18, 902–909

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giulio Maria Pasinetti.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Varghese, M., Ho, L., Wang, J. et al. Green coffee as a novel agent for Alzheimer’s disease prevention by attenuating diabetes. Translat.Neurosci. 5, 111–116 (2014). https://doi.org/10.2478/s13380-014-0213-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s13380-014-0213-y

Keywords

Navigation